Long before the blood clots, there were fears the Johnson & Johnson vaccine was a second-class shot compared with Moderna or Pfizer.
Source: Los Angeles Times
Long before the blood clots, there were fears the Johnson & Johnson vaccine was a second-class shot compared with Moderna or Pfizer.
Source: Los Angeles Times
Be First to Comment